Rohto Pharmaceutical (4527.T) Earnings Analysis

Rohto Pharmaceutical (4527.T) next reports earnings on 2026-08-06, consensus EPS 39.86 JPY. Last quarter (2026-02-12) it beat with EPS 47.03 JPY vs 44.11 JPY est (+6.6%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E 15.41.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4527.T next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate39.86 JPY
Revenue estimate87.05B

4527.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-1247.03 JPY44.11 JPY+6.6%Beat
2025-11-1326.04 JPY24.98 JPY+4.2%Beat
2025-02-1252.09 JPY49.09 JPY+6.1%Beat
2024-11-1319.46 JPY35.07 JPY-44.5%Miss

Beat rate: 3/4 (75%) over reported quarters with consensus data.

4527.T valuation and analyst view

Trailing P/E15.41
Trailing EPS151.54 JPY
Price / book1.75
Dividend yield1.97%
Market cap537.80B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Rohto Pharmaceutical (4527.T)'s next earnings date?

Rohto Pharmaceutical is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 39.86 JPY and revenue estimate of 87.05B.

Did 4527.T beat earnings last quarter?

In its 2026-02-12 report, 4527.T posted EPS of 47.03 JPY versus a 44.11 JPY estimate — a beat of 6.6%.

What is 4527.T's earnings track record?

Over the last 4 reported quarters with consensus data, 4527.T beat estimates 3 times (75%).

What is 4527.T's current P/E ratio and EPS?

4527.T trades at a trailing P/E of 15.41 on trailing EPS of 151.53781144498083 JPY.

What do analysts rate 4527.T?

4527.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.